New Initiative Aims To Reduce Clinical Trial Contacting Delays

Lexington, Ky. (June 26, 2015) — The UK Center for Clinical and Translational Science (CCTS) in conjunction with the Office of Sponsored Projects Administration (OSPA) has joined a new initiative designed to reduce clinical trial contracting delays. The Accelerated Clinical Trial Agreement (ACTA) was developed as part of the Clinical and Translational Science Award (CTSA) consortium, the funding mechanism from National Institutes of Health that supports the CCTS.

The ACTA will expedite the clinical trial negotiation process if the sponsoring agency is willing to accept a pre-approved template. Investigators interested in utilizing the ACTA for a clinical trial contract that needs to be negotiated should notify Dave Erem in OSPA at or 257-5993. OSPA will then contact the sponsoring agency and ask them to consider using the ACTA.  If the sponsor agrees, this will reduce the amount of time that it takes to finalize the clinical trial agreement. However, each sponsoring agency can decide whether or not they will accept the ACTA for negotiations.

Media Contact: Mallory Powell,